Previous close | 2.7000 |
Open | 2.6000 |
Bid | 1.2000 |
Ask | 3.5000 |
Strike | 65.00 |
Expiry date | 2024-07-19 |
Day's range | 1.4500 - 2.7500 |
Contract range | N/A |
Volume | |
Open interest | 243 |
Esperion's (ESPR) first-quarter earnings and sales beat estimates on the back of better-than-expected collaboration revenues.
Intra-Cellular (ITCI) reports first-quarter 2024 results, wherein both earnings and revenues beat estimates, driven by strong Caplyta sales.
Pacira (PCRX) reports first-quarter 2024 results, wherein earnings miss but revenues beat estimates, driven by Exparel sales.